The Journal of Urology
Volume 177, Issue 6 , Page 2140 , June 2007

Editorial Comment

References 

  1. Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351:1513
  2. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351:1502
  3. Glode LM, Barqawi A, Crighton F, Crawford ED, Kerbel R. Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma. Cancer. 2003;98:1643

PII: S0022-5347(07)00717-3

doi: 10.1016/j.juro.2007.01.269

The Journal of Urology
Volume 177, Issue 6 , Page 2140 , June 2007

Article Tools